COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 195 filers reported holding COHERUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,645 | +2.7% | 37,873 | +17.2% | 0.00% | – |
| Q2 2023 | $137,968 | -31.2% | 32,311 | +10.2% | 0.00% | – |
| Q1 2023 | $200,556 | -13.6% | 29,321 | 0.0% | 0.00% | – |
| Q4 2022 | $232,222 | -18.0% | 29,321 | -0.5% | 0.00% | – |
| Q3 2022 | $283,159 | +29.5% | 29,465 | -2.4% | 0.00% | – |
| Q2 2022 | $218,655 | -37.7% | 30,201 | +11.0% | 0.00% | – |
| Q1 2022 | $351,229 | -34.3% | 27,206 | -18.8% | 0.00% | – |
| Q4 2021 | $535,000 | -2.6% | 33,506 | -1.9% | 0.00% | – |
| Q3 2021 | $549,000 | +7.4% | 34,155 | -7.6% | 0.00% | – |
| Q2 2021 | $511,000 | +3.0% | 36,965 | +8.9% | 0.00% | – |
| Q1 2021 | $496,000 | -18.2% | 33,956 | -2.6% | 0.00% | -100.0% |
| Q4 2020 | $606,000 | -2.7% | 34,875 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $623,000 | +3.8% | 33,990 | -1.9% | 0.00% | 0.0% |
| Q2 2020 | $600,000 | -7.6% | 34,641 | -13.4% | 0.00% | 0.0% |
| Q1 2020 | $649,000 | -3.0% | 39,988 | +7.7% | 0.00% | 0.0% |
| Q4 2019 | $669,000 | -14.9% | 37,140 | -3.2% | 0.00% | 0.0% |
| Q3 2019 | $786,000 | -7.7% | 38,376 | -0.5% | 0.00% | 0.0% |
| Q2 2019 | $852,000 | +80.9% | 38,571 | +11.7% | 0.00% | 0.0% |
| Q1 2019 | $471,000 | +60.8% | 34,519 | +6.8% | 0.00% | – |
| Q4 2018 | $293,000 | -48.5% | 32,333 | -6.3% | 0.00% | -100.0% |
| Q3 2018 | $569,000 | +12.7% | 34,490 | -4.3% | 0.00% | 0.0% |
| Q2 2018 | $505,000 | +45.5% | 36,053 | +15.0% | 0.00% | – |
| Q1 2018 | $347,000 | +25.7% | 31,349 | -0.1% | 0.00% | – |
| Q4 2017 | $276,000 | -32.5% | 31,377 | +2.3% | 0.00% | – |
| Q3 2017 | $409,000 | -6.2% | 30,680 | +0.9% | 0.00% | -100.0% |
| Q2 2017 | $436,000 | -14.3% | 30,393 | +26.3% | 0.00% | 0.0% |
| Q1 2017 | $509,000 | -11.9% | 24,066 | +17.3% | 0.00% | 0.0% |
| Q4 2016 | $578,000 | +4.5% | 20,524 | -0.6% | 0.00% | 0.0% |
| Q3 2016 | $553,000 | +57.5% | 20,647 | -0.7% | 0.00% | 0.0% |
| Q2 2016 | $351,000 | +11.8% | 20,786 | +27.5% | 0.00% | – |
| Q1 2016 | $314,000 | -15.1% | 16,297 | +1.1% | 0.00% | – |
| Q4 2015 | $370,000 | +15.6% | 16,117 | +1.1% | 0.00% | – |
| Q3 2015 | $320,000 | -29.2% | 15,943 | +2.1% | 0.00% | -100.0% |
| Q2 2015 | $452,000 | +232.4% | 15,622 | +250.9% | 0.00% | – |
| Q1 2015 | $136,000 | – | 4,452 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |